Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects

被引:63
作者
Chen, JW
Hojlund, K
Beck-Nielsen, H
Christiansen, JS
Orskov, H
Frystyk, J
机构
[1] Aarhus Univ Hosp, Med Res Labs, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Dept Med M, DK-8000 Aarhus C, Denmark
[3] Aarhus Univ Hosp, Lab Biochem Pathol, DK-8000 Aarhus C, Denmark
[4] Odense Univ Hosp, Diabet Res Ctr, DK-5000 Odense C, Denmark
[5] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense C, Denmark
关键词
D O I
10.1210/jc.2004-0039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pituitary GH secretion is feedback regulated by circulating IGF-I. However, it remains to be determined whether the feedback control is mediated through circulating free or total IGF-I. To study this, we compared the temporal changes in circulating levels of GH vs. free and total IGF-I during fasting. Seventeen healthy normal-weight subjects (body mass index 23.4 +/- 0.6 kg/m(2)) were studied during 80 h of fasting. Serum was assayed for GH every 3 h; total, free, and bioactive IGF-I, IGF binding protein (IGFBP)-1, -2, and -3 as well as IGFBP-1 bound IGF-I were assayed every morning. During fasting, mean 24-h GH levels increased from 1.41 +/- 0.20 to 3.01 +/- 0.46 and 2.09 +/- 0.30 mug/liter (d 1 vs. d 2 and 3; P < 0.03). After 24 h of fasting, free and bioactive IGF-I had decreased by 40 +/- 5 and 17 +/- 5%, respectively (P < 0.02), and both concentrations remained suppressed for the rest of the study. In contrast, total IGF-I remained unchanged until the end of d 3, at which levels were slightly reduced (P < 0.007). IGFBP-1 increased from 38 +/- 2 to137 +/- 24, 212 +/- 32, and 214 +/- 22 mu g/liter (d 1 vs. d 2, d 3, and end of d 3; P < 0.0001), and these changes closely paralleled those of IGFBP-1- bound IGF-I (P < 0.0001). IGFBP-2 increased only transiently at d 2 (P < 0.05), and IGFBP-3 remained unchanged. The increase in mean 24-h GH levels from d 1 to d 2 correlated inversely with the relative reduction in free IGF-I from d 1 to d 2 (r = -0.51; P = 0.04), i.e. the larger the reduction in free IGF-I, the larger the increase in GH. None of the other IGF-related parameters correlated with GH. In conclusion, the temporal relationship between the increase in GH and the reduction in free IGF-I supports the hypothesis that circulating free IGF-I mediates the feedback regulation of GH secretion.
引用
收藏
页码:366 / 371
页数:6
相关论文
共 32 条
[1]   INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS AS GLUCOREGULATORS [J].
BAXTER, RC .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (10) :12-17
[2]   THE EFFECT OF FASTING ON LIVER RECEPTORS FOR PROLACTIN AND GROWTH-HORMONE [J].
BAXTER, RC ;
BRYSON, JM ;
TURTLE, JR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (11) :1086-1090
[3]  
Brisse H, 1994, B ASS INFORMATIQUE, V1, P1
[4]   Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): Evidence for a suppressive action of free rather than bound IGF-I [J].
Chapman, IM ;
Hartman, ML ;
Pieper, KS ;
Skiles, EH ;
Pezzoli, SS ;
Hintz, RL ;
Thorner, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08) :2836-2842
[5]   A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum [J].
Chen, JW ;
Ledet, T ;
Orskov, H ;
Jessen, N ;
Lund, S ;
Whittaker, J ;
De Meyts, P ;
Larsen, MB ;
Christiansen, JS ;
Frystyk, J .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (06) :E1149-E1155
[6]   VARIABLES CONTROLLING THE SECRETION OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-2 IN NORMAL HUMAN-SUBJECTS [J].
CLEMMONS, DR ;
SNYDER, DK ;
BUSBY, WH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (04) :727-733
[7]   THE REGULATION OF INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN (IGFBP)-1 DURING PROLONGED FASTING [J].
COTTERILL, AM ;
HOLLY, JMP ;
WASS, JAH .
CLINICAL ENDOCRINOLOGY, 1993, 39 (03) :357-362
[8]   The circulating IGF system and its relationship with 24-h glucose regulation and insulin sensitivity in healthy subjects [J].
Frystyk, J ;
Nyholm, B ;
Skjærbæk, C ;
Baxter, RC ;
Schmitz, O ;
Orskov, H .
CLINICAL ENDOCRINOLOGY, 2003, 58 (06) :777-784
[9]   FREE INSULIN-LIKE GROWTH-FACTORS (IGF-I AND IGF-II) IN HUMAN SERUM [J].
FRYSTYK, J ;
SKJAERBAEK, C ;
DINESEN, B ;
ORSKOV, H .
FEBS LETTERS, 1994, 348 (02) :185-191
[10]  
Frystyk J, 1995, GROWTH REGULAT, V5, P169